NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.”

Patients 279

Patients Therapy Data Safety 279

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Introduction. Search strategy.

Safety 52

Safety Cannabinoids Events Data 52

SpeedWeed

FEBRUARY 21, 2021

The human primary blood cell screens performed at MSU are state-of-the-science models for evaluating the effects of compounds on the human immune system,” said Kaminski, director of the Institute for Integrative Toxicology, Professor of Pharmacology & Toxicology, and director of MSU’s Center for Research on Ingredient Safety.

Treatment 52

Treatment Research and Development Cannabinoids Data 52

Veriheal

SEPTEMBER 23, 2021

Fortunately, one such man, Levi Barker, provided us with some much-needed insight into what the substance is, how it is used in treatment, and more. Veriheal: What are some of the most common conditions you treat with iboga? All human conditions depend on healing physically, mentally, and spiritually.

Treatment 98

Treatment Medicine Research and Development Therapy 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? of patients experience pain after curative treatment, while 66.4% in cancer patients undergoing anticancer treatment, 50.7% in those who had completed treatment, and as high as 66.7%

Medicine 96

Medicine Treatment Patients Data 96

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Forward-Looking Statements.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

NOVEMBER 21, 2023

Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments. The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit.

Research and Development 93

Research and Development Consumption Education Data 93

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Canna Law Blog

DECEMBER 16, 2021

The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” Expansive List of Qualifying Medical Conditions.

Legislation 96

Legislation Treatment Therapy Conditions 96

Veriheal

MAY 19, 2023

The review period will give employers a chance to identify safety-sensitive positions for which the new drug test ban is not appropriate. SB 5132 already has a number of exceptions built-in for safety-sensitive jobs like law enforcement, firefighting, and first responders. So, how exactly is ketamine able to do this?

Chronic Pain 79

Chronic Pain Data Consumption Safety 79

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 64

Safety Food CBD Oil 64

The Cannigma

DECEMBER 20, 2021

terpenes ) may help treat a number of different skin conditions. Some of these have been identified as possible targets for the treatment of inflammatory skin conditions. These methods may include: regular consumption inhalation oral administration local treatment via topical products.

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Sapphire-Pricing-and-Timelines-v1.4. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

APRIL 1, 2022

The General Council of Pharmacists has proposed this Monday to carry out a pilot test in pharmacies to assess the use of cannabis for therapeutic purposes, a product that, in the opinion of the president of pharmacists, could have a similar use and conditions of use to those that have other compounds such as morphine.

Medicine 52

Medicine Data Safety Conditions 52

Cannabis Law Report

JUNE 19, 2022

Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. This latest partnership further strengthens Beckley Psytech’s digital strategy to develop personalised, end-to-end treatment programmes for patients in areas of significant unmet medical need. About 5-MeO-DMT.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 105

Consumption Patients Research and Development Data 105

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Veriheal

AUGUST 22, 2022

Based on the details of a June 21 press release, the trials—which are taking place in Johannesburg—are the first ethically approved studies exploring the suitability and safety of using cannabis as a substitute for opioid pain relievers. . S tudy subjects must be willing and ready to substitute opioids with cannabis. “We

Clinical Trials 111

Clinical Trials Chronic Pain Hydroponic Strains 111

Cannabis Law Report

FEBRUARY 28, 2022

CBD Oil is a treatment for the following health issues in dogs. Although there are no conclusive scientific studies on CBD being used for the treatment of dogs, there is evidence from dog owners that CBD may help to manage seizures. It will evaluate the effectiveness of CBD in treating epileptic dogs that are resistant to treatment.

Oil 52

Oil Blood Pressure CBD Tincture 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

OCTOBER 22, 2021

Cybin’s Research and Development team has completed 74 in-vitro and in-vivo evaluations of Cybin’s expanding portfolio of psychedelic compounds being designed for potential therapeutic applications for several mental health conditions.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

DECEMBER 26, 2021

The patent relates to improved technology for detection and maintenance of the optimal therapeutic psychedelic state, which Entheon intends to study through the monitoring of electroencephalogram (EEG) biomarkers in order to optimize the treatment of neuropsychiatric conditions. US Provisional Patent Filed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

AUGUST 12, 2021

To grow cannabis, a person must hold a license from the State Institute for Drug Control for the cultivation of cannabis for medical use Authorization for the handling of addictive substances and preparations for activities related to the treatment of cannabis is also required.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

The Cannigma

OCTOBER 21, 2021

Attention deficit hyperactivity disorder, or ADHD, is a condition characterized by behavioral symptoms such as inattentiveness, hyperactivity, impulsiveness. While there has been little systematic research on using cannabis for ADHD, many patients with the condition report positive effects from using cannabis. What is ADHD?

Blood Pressure 137

Blood Pressure Treatment Patients Cannabis 137

Cannabis Law Report

JUNE 12, 2021

She says the treatment did little but left her feeling numb and unable to heal. “The data was showing that psychedelics were providing benefits to people suffering from anxiety, depression, addiction and PTSD. The treatments were carefully dosed and conducted under medical supervision.

Therapy 105

Therapy Treatment Medicine Sleep 105

Puff Puff Post

MARCH 10, 2020

.” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

AUGUST 27, 2021

The Rules aim to promote social equity, safety and easy access to the cannabis marketplace while keeping local municipalities in control of how they want cannabis businesses to operate in their jurisdiction. New applicants may apply for either a conditional license or an annual license.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Cannabis Law Report

AUGUST 16, 2021

It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child.

Safety 116

Safety Patients Cannabis Law 116

Veriheal

DECEMBER 23, 2022

Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues.

Research and Development 77

Research and Development Agriculture Data Extraction 77

Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. Specifically, the agency fears that.

CBD 90

CBD Safety Topical Food 90

SpeedWeed

MARCH 5, 2021

The investigators then performed an analysis of the data to quantify the relationships between lifetime cannabis use, 12-month cannabis use, and 12-month cannabis use frequency (at least monthly use and less than monthly use) and incidence of hypertension. Subjects in the study consumed cannabis by smoking or via oral cannabis oil extracts.

Blood Pressure 52

Blood Pressure Marijuana Data Therapy 52